• Sun. Jan 24th, 2021

Dimancherouge

Technology

ADC

  • Home
  • Dr. Jutta Wanner Joins Her Next Generation ADC Technology at OS Therapies as Chief Technology Officer

Dr. Jutta Wanner Joins Her Next Generation ADC Technology at OS Therapies as Chief Technology Officer

CAMBRIDGE, Md., Oct. 9, 2020 /PRNewswire/ — OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS) and other deadly cancers in kids…

Synaffix Wins Best Platform Technology at 7th Annual World ADC Awards | Region

AMSTERDAM–(BUSINESS WIRE)–Sep 22, 2020– Synaffix B.V., a biotechnology company enabling antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announces that it has won the “Best ADC Platform Technology” category at the…